The Pharmacy and Poisons Board (PPB) launch an investigation the death one person who died after taking the COVID-19 AstraZeneca vaccine in Kenya.
According to Dr Peter Ikamati, Deputy Director, PER, at the PPB, the death could have been prompted by a miscarriage and not certainly the vaccine.
He added that the Board will state the event, which resulted in Uasin Gishu, on Friday.
“What we can say is it was exaggerated, an expectant female got a miscarriage, it occurred within the period of being given a vaccine. Miscarriage could have happened, it does not have to be linked to the jab,” he said on Wednesday.
“Because of the seriousness of the matter, when a critical case is reported, PPB will follow up within 24hours.”
Dr Ikamati added that 279 people had unfriendly effects after taking the vaccine, with 7 others undergoing critical symptoms.
The Health Ministry added 370,000 Kenyans have so far been vaccinated against COVID-19, with Lamu reporting the minimal number of people at 262.
“You can get vaccinated today and it does not mean you can’t suffer any other impacts such as hypertension or diarrhoea… If this happens after the vaccine, it may not mean such effects were caused by the vaccine,” said Dr Collins Tabu, Head of Immunization, Ministry of Health.
Dr Tabu said that Kenya is projected to spend more than Ksh.36 billion to address the COVID-19 AstraZeneca vaccine.
Post a Comment
What is your say on this